Table 3.

Independent prognostic factors of uterus adenosarcoma patients.

	Univariate analysis		Multivariate analysis
	HR (95% CI)	P value	HR (95% CI)	P value
Age (yrs)
<56	1		1
≥56	2.026 (1.509–2.719)	<.001	1.897 (1.394–2.581)	<.001
Marital status
Yes	1		1
No	1.496 (1.134–1.974)	.004	1.375 (1.036–1.825)	.028
Unknown	1.730 (0.898–3.332)	.101	1.598 (0.821–3.112)	.168
Race
White	1
Black	1.192 (0.822–1.728)	.354
Other*	0.912 (0.602–1.382)	.665
Unknown	0.000 (0.000–1.267)	.946
Multiple lesions
No	1
Yes	1.242 (0.916–1.684)	.164
Largest tumor size (mm)
≤48	1		1
>48	2.482 (1.834–3.359)	<.001	1.685 (1.226–2.316)	.001
Grade
Grade I	1		1
Grade II	1.262 (0.672–2.373)	.469	1.264 (0.672–2.382)	.469
Grade III	5.801 (3.100–10.853)	<.001	2.533 (1.301–4.934)	.006
Grade IV	3.543 (1.976–6.356)	<.001	2.585 (1.419–4.709)	.002
Unknown	1.278 (0.724–2.257)	.397	1.141 (0.644–2.019)	.651
T stage
T1	1		1
T2	3.466 (1.703–7.051)	.001	3.388 (1.641–6.994)	.001
T3	11.911 (5.815–24.399)	<.001	6.957 (3.254–14.876)	<.001
T4	4.065 (0.560–29.495)	.165	2.523 (0.336–18.931)	.368
Tx	1.155 (0.826–1.615)	.398	1.370 (0.975–1.925)	.070
Lymph node dissection
Yes	1
No	0.943 (0.718–1.238)	.673
Radiotherapy
No	1		1
Yes	1.746 (1.300–2.346)	<.001	1.036 (0.753–1.426)	.826
Chemotherapy
No	1		1
Yes	2.382 (1.732–3.276)	<.001	1.827 (1.291–2.586)	.001

CI = confidence interval, HR = hazard ratio.

^*Others: American Indian/AK Native, Asian/Pacific Islander.